OPCH Key Statistics, Chart & Performance
The current stock price of OPCH is 31.22 USD. In the past month the price increased by 10.71%. In the past year, price increased by 31.18%.
OPCH Latest News, Press Relases and Analysis
OPCH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.46 | 99.53B | ||
| CI | THE CIGNA GROUP | 9.79 | 74.32B | ||
| LH | LABCORP HOLDINGS INC | 17.06 | 22.37B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.71 | 21.51B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.29 | 21.37B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.02B | ||
| DVA | DAVITA INC | 13.15 | 8.68B | ||
| HIMS | HIMS & HERS HEALTH INC | 68.69 | 8.38B | ||
| CHE | CHEMED CORP | 20.03 | 6.42B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.51 | 6.42B | ||
| RDNT | RADNET INC | 218.18 | 6.38B | ||
| WGS | GENEDX HOLDINGS CORP | 89.1 | 4.81B |
Related stock screener links
About OPCH
Company Profile
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,015 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
Company Info
OPTION CARE HEALTH INC
3000 Lakeside Dr, Suite 300N
Bannockburn ILLINOIS 60015 US
CEO: John C. Rademacher
Employees: 7052
Phone: 13129402443
OPTION CARE HEALTH INC / OPCH FAQ
What does OPTION CARE HEALTH INC do?
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,015 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
What is the current price of OPCH stock?
The current stock price of OPCH is 31.22 USD. The price increased by 4.34% in the last trading session.
What is the dividend status of OPTION CARE HEALTH INC?
OPCH does not pay a dividend.
How is the ChartMill rating for OPTION CARE HEALTH INC?
OPCH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists OPCH stock?
OPCH stock is listed on the Nasdaq exchange.
OPCH Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to OPCH. When comparing the yearly performance of all stocks, OPCH is one of the better performing stocks in the market, outperforming 86.09% of all stocks.
OPCH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to OPCH. OPCH scores excellent on profitability, but there are some minor concerns on its financial health.
OPCH Financial Highlights
Over the last trailing twelve months OPCH reported a non-GAAP Earnings per Share(EPS) of 1.49. The EPS increased by 25.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.78% | ||
| ROA | 6.01% | ||
| ROE | 15.39% | ||
| Debt/Equity | 0.85 |
OPCH Forecast & Estimates
17 analysts have analysed OPCH and the average price target is 35.7 USD. This implies a price increase of 14.35% is expected in the next year compared to the current price of 31.22.
For the next year, analysts expect an EPS growth of 43.3% and a revenue growth 14.01% for OPCH